Exact Mass: 522.2134718
Exact Mass Matches: 522.2134718
Found 500 metabolites which its exact mass value is equals to given mass value 522.2134718
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Isobrucein A
A quassinoid consisting of a heteropentacyclic skeleton containing a delta-lactone moiety which is substituted at the alpha-carbon by a 3-methylbutanoyloxy group.
Icariside E5
Icariside E5 is a glycoside and a stilbenoid. Icariside E5 is a natural product found in Brainea insignis and Capsicum annuum with data available. Icariside E5 is found in fruits. Icariside E5 is a constituent of ripe fruits of Capsicum annuum var. acuminatum
Isolariciresinol 9'-O-beta-D-glucoside
Isolariciresinol 9-O-beta-D-glucoside is a constituent of Scots pine (Pinus sylvestris) needles. Constituent of Scots pine (Pinus sylvestris) needles
(7'R,8'R)-4,7'-Epoxy-3',5-dimethoxy-4',9,9'-lignanetriol 9'-glucoside
(7R,8R)-4,7-Epoxy-3,5-dimethoxy-4,9,9-lignanetriol 9-glucoside is found in alcoholic beverages. (7R,8R)-4,7-Epoxy-3,5-dimethoxy-4,9,9-lignanetriol 9-glucoside is isolated from Riesling wine. Isolated from Riesling wine. (7R,8R)-4,7-Epoxy-3,5-dimethoxy-4,9,9-lignanetriol 9-glucoside is found in alcoholic beverages.
Isolariciresinol 4'-O-beta-D-glucoside
Isolariciresinol 4-O-beta-D-glucoside is found in alcoholic beverages. Isolariciresinol 4-O-beta-D-glucoside is a constituent of Riesling wine. Constituent of Riesling wine. Isolariciresinol 4-O-beta-D-glucoside is found in alcoholic beverages.
Isolariciresinol 9-O-beta-D-glucoside
Isolariciresinol 9-O-beta-D-glucoside is a constituent of Scots pine (Pinus sylvestris) needles. Constituent of Scots pine (Pinus sylvestris) needles.
PA(2:0/5-iso PGF2VI)
PA(2:0/5-iso PGF2VI) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/5-iso PGF2VI), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 5-iso Prostaglandin F2alpha-VI at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(5-iso PGF2VI/2:0)
PA(5-iso PGF2VI/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(5-iso PGF2VI/2:0), in particular, consists of one chain of one 5-iso Prostaglandin F2alpha-VI at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
BRUCEIN A
Bruceine A is a quassinoid. Bruceine A is a natural product found in Brucea javanica with data available. Bruceine A(NSC310616; Dihydrobrusatol) is a natural quassinoid compound extracted from the dried fruits of Brucea javanica (L.); are potential candidates for the treatment of canine babesiosis. IC50 value: Target: Bruceine A inhibited the in vitro growth of Babesia gibsoni in canine erythrocytes at lower concentration compared with the standard antibabesial drug diminazene aceturate and killed the parasites within 24 hr at a concentration of 25 nM. Oral administration of bruceine A at a dosage of 6.4 mg/kg/day for 5 days resulted in no clinical findings in a dog with normal ranges of hematological and biochemical values in the blood. Three dogs were infected with B. gibsoni and two of them were treated with bruceine A at a dosage of 6.4 mg/kg/day for 6 days from day 5 post-infection. Bruceine A(NSC310616; Dihydrobrusatol) is a natural quassinoid compound extracted from the dried fruits of Brucea javanica (L.); are potential candidates for the treatment of canine babesiosis. IC50 value: Target: Bruceine A inhibited the in vitro growth of Babesia gibsoni in canine erythrocytes at lower concentration compared with the standard antibabesial drug diminazene aceturate and killed the parasites within 24 hr at a concentration of 25 nM. Oral administration of bruceine A at a dosage of 6.4 mg/kg/day for 5 days resulted in no clinical findings in a dog with normal ranges of hematological and biochemical values in the blood. Three dogs were infected with B. gibsoni and two of them were treated with bruceine A at a dosage of 6.4 mg/kg/day for 6 days from day 5 post-infection.
Bruceine
Bruceine A is a quassinoid. Bruceine A is a natural product found in Brucea javanica with data available. Bruceine A(NSC310616; Dihydrobrusatol) is a natural quassinoid compound extracted from the dried fruits of Brucea javanica (L.); are potential candidates for the treatment of canine babesiosis. IC50 value: Target: Bruceine A inhibited the in vitro growth of Babesia gibsoni in canine erythrocytes at lower concentration compared with the standard antibabesial drug diminazene aceturate and killed the parasites within 24 hr at a concentration of 25 nM. Oral administration of bruceine A at a dosage of 6.4 mg/kg/day for 5 days resulted in no clinical findings in a dog with normal ranges of hematological and biochemical values in the blood. Three dogs were infected with B. gibsoni and two of them were treated with bruceine A at a dosage of 6.4 mg/kg/day for 6 days from day 5 post-infection. Bruceine A(NSC310616; Dihydrobrusatol) is a natural quassinoid compound extracted from the dried fruits of Brucea javanica (L.); are potential candidates for the treatment of canine babesiosis. IC50 value: Target: Bruceine A inhibited the in vitro growth of Babesia gibsoni in canine erythrocytes at lower concentration compared with the standard antibabesial drug diminazene aceturate and killed the parasites within 24 hr at a concentration of 25 nM. Oral administration of bruceine A at a dosage of 6.4 mg/kg/day for 5 days resulted in no clinical findings in a dog with normal ranges of hematological and biochemical values in the blood. Three dogs were infected with B. gibsoni and two of them were treated with bruceine A at a dosage of 6.4 mg/kg/day for 6 days from day 5 post-infection.
trans-Dihydrodehydrodiconiferyl alcohol-9-O-beta-D-glucoside
(2S,3R)-Dihydrodehydrodiconiferyl alcohol beta-D-glucoside
Carpelastofuran
(7S,8R)-Dehydrodiconiferyl alcohol 9-O-beta-glucopyranoside
(2R,3R,4S,5S,6R)-2-[3-[2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]propoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
4-{2-[[3-(4-hydroxy-3-methoxyphenyl)-2-propenyl]oxy]ethyl}-2,6-dimethoxyphenyl-beta-D-glucopyranoside
(+)-lariciresinol-4-O-beta-D-glucopyranoside|(-)-lariciresinol-4-O-beta-D-glucopyranoside|7S,8R,8R-(-)-lariciresinol-4-O-beta-D-glucopyranoside|lariciresinol 4-O-beta-D-glucopyranoside
2-[4,5-Dimethoxy-5-(3-phenyl-trans-allyl)cyclohexa-3,6-dien-2-on-1-ylmethyl]-5-hydroxy-6-methoxy-3-phenylbenzofuran
11beta,12beta-Epoxide,2,3,14-tri-Ac-8,17-Epoxy-2,3,9,14-tetrahydroxy-5,11-briaradien-18,7-olide
(-)-4,4,9-trihydroxy-3,5-dimethoxy-2,7-cyclolignan 9-O-beta-D-glucopyranoside
11,16-dihydroxy-12-O-beta-D-glucopyranosyl-17(15->16),18(4->3)-abeo-4-carboxy-3,8,11,13-abietatetraen-7-one
5-methoxy-9-beta-xylopyranosyl-(-)-isolariciresinol
2-(3,5-Dimethoxy-4-(3,4,5-trihydroxytetrahydro-2H-pyran-2-yloxy)phenyl)-3-hydroxymethyl-7-methoxy-2,3-dihydrobenzofuran 5-(1-propanol)
seco-dehydrodiconiferyl alcohol-4-O-beta-D-glucopyranoside
(+)-4,4-O-diangeloylpinoresinol|(1S,3aR,4S,6aR)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diylbis-[2-methoxybenzene-4,1-diyl] bis[(2Z)-2-methylbut-2-enoate]
[(1S,2S,3R)-1,2,3,4-tetrahydro-7-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxynaphthalen-2-yl]methyl beta-D-xylopyranoside
(11beta)-1,2,21,23-tetrahydro-11,23-dihydroxy-21-oxoobacunoic acid
2-[4,5-Dimethoxy-2-(3-phenyl-trans-allyloxy)benzyl]-5-hydroxy-6-methoxy-3-phenylbenzofuran
Urolignoside
Urolignoside is a natural product found in Salacia chinensis, Keteleeria evelyniana, and other organisms with data available.
(+)-Isolariciresinol 9O-Glucoside
(+)-Isolariciresinol 9-O-glucoside is a natural product found in Pedicularis densispica, Glochidion zeylanicum, and other organisms with data available.
Azatadine maleate
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Azatadine bimaleate is an inhibitor of histamine receptors and choline receptors with IC50s of 6.5 nM and 10 nM respectively.
Asperphenamate analogue phenylalanine to tyrosine substitution
(7R,8S)-dihydrodehydrodiconiferyl alcohol 9-O-beta-D-glucopyranoside
methyl 3-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-2-[[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]methyl]-4-methoxy-5-oxofuran-2-carboxylate
(2R,3R,4S,5S,6R)-2-[[7-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-6-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
methyl 3-[3,4-dihydroxy-2-(3-methylbut-2-enyl)phenyl]-2-[[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]methyl]-4-methoxy-5-oxofuran-2-carboxylate
2-(hydroxymethyl)-6-[5-[3-(hydroxymethyl)-5-(3-hydroxypropyl)-7-methoxy-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]oxane-3,4,5-triol
C26H34O11_beta-D-Glucopyranoside, [(2R,3R)-2,3-dihydro-2-(4-hydroxy-3-methoxyphenyl)-5-(3-hydroxypropyl)-7-methoxy-3-benzofuranyl]methyl
C26H34O11_[(2R,3R,4S)-6-Hydroxy-4-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl]methyl beta-D-glucopyranoside
C26H34O11_3-[2-(4-Hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]propyl beta-D-glucopyranoside
C26H34O11_2-{2-Hydroxy-5-[(1E)-3-hydroxy-1-propen-1-yl]-3-methoxyphenyl}-3-(4-hydroxy-3-methoxyphenyl)propyl hexopyranoside
2-(hydroxymethyl)-6-[5-[3-(hydroxymethyl)-5-(3-hydroxypropyl)-7-methoxy-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]oxane-3,4,5-triol
methyl 3-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-2-[[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]methyl]-4-methoxy-5-oxofuran-2-carboxylate
(2R,3R,4S,5S,6R)-2-[[7-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-6-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
methyl 3-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-2-[[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]methyl]-4-methoxy-5-oxofuran-2-carboxylate [IIN-based on: CCMSLIB00000845235]
methyl 3-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-2-[[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]methyl]-4-methoxy-5-oxofuran-2-carboxylate [IIN-based: Match]
methyl 3-[3,4-dihydroxy-2-(3-methylbut-2-enyl)phenyl]-2-[[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]methyl]-4-methoxy-5-oxofuran-2-carboxylate [IIN-based on: CCMSLIB00000846693]
methyl 3-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-2-[[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]methyl]-4-methoxy-5-oxofuran-2-carboxylate [IIN-based on: CCMSLIB00000845233]
methyl 3-[3,4-dihydroxy-2-(3-methylbut-2-enyl)phenyl]-2-[[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]methyl]-4-methoxy-5-oxofuran-2-carboxylate [IIN-based: Match]
(2R,3R,4S,5S,6R)-2-[[7-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-6-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major
(2R,3R,4S,5S,6R)-2-[3-[2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]propoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major
2-(hydroxymethyl)-6-[5-[3-(hydroxymethyl)-5-(3-hydroxypropyl)-7-methoxy-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]oxane-3,4,5-triol_major
Cys Lys Ser Trp
Cys Lys Trp Ser
Cys Met Asn Arg
C18H34N8O6S2 (522.2042624000001)
Cys Met Arg Asn
C18H34N8O6S2 (522.2042624000001)
Cys Asn Met Arg
C18H34N8O6S2 (522.2042624000001)
Cys Asn Arg Met
C18H34N8O6S2 (522.2042624000001)
Cys Arg Met Asn
C18H34N8O6S2 (522.2042624000001)
Cys Arg Asn Met
C18H34N8O6S2 (522.2042624000001)
Cys Ser Lys Trp
Cys Ser Trp Lys
Cys Trp Lys Ser
Cys Trp Ser Lys
Asp Phe Asn Gln
Asp Phe Gln Asn
Asp Asn Phe Gln
Asp Asn Gln Phe
Asp Gln Phe Asn
Asp Gln Asn Phe
Glu Phe Met Pro
Glu Phe Asn Asn
Glu Phe Pro Met
Glu His His Thr
Glu His Thr His
Glu Ile Met Met
Glu Leu Met Met
Glu Met Phe Pro
Glu Met Ile Met
Glu Met Leu Met
Glu Met Met Ile
Glu Met Met Leu
Glu Met Pro Phe
Glu Asn Phe Asn
Glu Asn Asn Phe
Glu Pro Phe Met
Glu Pro Met Phe
Glu Thr His His
Phe Asp Asn Gln
Phe Asp Gln Asn
Phe Glu Met Pro
Phe Glu Asn Asn
Phe Glu Pro Met
Phe Gly His Tyr
Phe Gly Asn Trp
Phe Gly Trp Asn
Phe Gly Tyr His
Phe His Gly Tyr
Phe His Tyr Gly
Phe Met Glu Pro
Phe Met Pro Glu
Phe Asn Asp Gln
Phe Asn Glu Asn
Phe Asn Gly Trp
Phe Asn Asn Glu
Phe Asn Gln Asp
Phe Asn Trp Gly
Phe Pro Glu Met
Phe Pro Met Glu
Phe Gln Asp Asn
Phe Gln Asn Asp
Phe Trp Gly Asn
Phe Trp Asn Gly
Phe Tyr Gly His
Phe Tyr His Gly
Gly Phe His Tyr
Gly Phe Asn Trp
Gly Phe Trp Asn
Gly Phe Tyr His
Gly His Phe Tyr
Gly His Tyr Phe
Gly Asn Phe Trp
Gly Asn Trp Phe
Gly Trp Phe Asn
Gly Trp Asn Phe
Gly Tyr Phe His
Gly Tyr His Phe
His Glu His Thr
His Glu Thr His
His Phe Gly Tyr
His Phe Tyr Gly
His Gly Phe Tyr
His Gly Tyr Phe
His His Glu Thr
His His Thr Glu
His Thr Glu His
His Thr His Glu
His Tyr Phe Gly
His Tyr Gly Phe
Ile Glu Met Met
Ile Met Glu Met
Ile Met Met Glu
Lys Cys Ser Trp
Lys Cys Trp Ser
Lys Met Met Asn
Lys Met Asn Met
Lys Asn Met Met
Lys Ser Cys Trp
Lys Ser Trp Cys
Lys Trp Cys Ser
Lys Trp Ser Cys
Leu Glu Met Met
Leu Met Glu Met
Leu Met Met Glu
Met Cys Asn Arg
C18H34N8O6S2 (522.2042624000001)
Met Cys Arg Asn
C18H34N8O6S2 (522.2042624000001)
Met Glu Phe Pro
Met Glu Ile Met
Met Glu Leu Met
Met Glu Met Ile
Met Glu Met Leu
Met Glu Pro Phe
Met Phe Glu Pro
Met Phe Pro Glu
Met Ile Glu Met
Met Ile Met Glu
Met Lys Met Asn
Met Lys Asn Met
Met Leu Glu Met
Met Leu Met Glu
Met Met Glu Ile
Met Met Glu Leu
Met Met Ile Glu
Met Met Lys Asn
Met Met Leu Glu
Met Met Asn Lys
Met Asn Cys Arg
C18H34N8O6S2 (522.2042624000001)
Met Asn Lys Met
Met Asn Met Lys
Met Asn Arg Cys
C18H34N8O6S2 (522.2042624000001)
Met Pro Glu Phe
Met Pro Phe Glu
Met Arg Cys Asn
C18H34N8O6S2 (522.2042624000001)
Met Arg Asn Cys
C18H34N8O6S2 (522.2042624000001)
Asn Cys Met Arg
C18H34N8O6S2 (522.2042624000001)
Asn Cys Arg Met
C18H34N8O6S2 (522.2042624000001)
Asn Asp Phe Gln
Asn Asp Gln Phe
Asn Glu Phe Asn
Asn Glu Asn Phe
Asn Phe Asp Gln
Asn Phe Glu Asn
Asn Phe Gly Trp
Asn Phe Asn Glu
Asn Phe Gln Asp
Asn Phe Trp Gly
Asn Gly Phe Trp
Asn Gly Trp Phe
Asn Lys Met Met
Asn Met Cys Arg
C18H34N8O6S2 (522.2042624000001)
Asn Met Lys Met
Asn Met Met Lys
Asn Met Arg Cys
C18H34N8O6S2 (522.2042624000001)
Asn Asn Glu Phe
Asn Asn Phe Glu
Asn Gln Asp Phe
Asn Gln Phe Asp
Asn Arg Cys Met
C18H34N8O6S2 (522.2042624000001)
Asn Arg Met Cys
C18H34N8O6S2 (522.2042624000001)
Asn Trp Phe Gly
Asn Trp Gly Phe
Pro Glu Phe Met
Pro Glu Met Phe
Pro Glu Tyr Asp
Pro Phe Glu Met
Pro Phe Met Glu
Pro Met Glu Phe
Pro Met Phe Glu
Pro Tyr Asp Glu
Gln Asp Phe Asn
Gln Asp Asn Phe
Gln Phe Asp Asn
Gln Phe Asn Asp
Gln Asn Asp Phe
Gln Asn Phe Asp
Arg Cys Met Asn
C18H34N8O6S2 (522.2042624000001)
Arg Cys Asn Met
C18H34N8O6S2 (522.2042624000001)
Arg Met Cys Asn
C18H34N8O6S2 (522.2042624000001)
Arg Met Asn Cys
C18H34N8O6S2 (522.2042624000001)
Arg Asn Cys Met
C18H34N8O6S2 (522.2042624000001)
Arg Asn Met Cys
C18H34N8O6S2 (522.2042624000001)
Ser Cys Lys Trp
Ser Cys Trp Lys
Ser Lys Cys Trp
Ser Lys Trp Cys
Ser Trp Cys Lys
Ser Trp Lys Cys
Thr Glu His His
Thr His Glu His
Thr His His Glu
Trp Cys Lys Ser
Trp Cys Ser Lys
Trp Phe Gly Asn
Trp Phe Asn Gly
Trp Gly Phe Asn
Trp Gly Asn Phe
Trp Lys Cys Ser
Trp Lys Ser Cys
Trp Asn Phe Gly
Trp Asn Gly Phe
Trp Ser Cys Lys
Trp Ser Lys Cys
Tyr Phe Gly His
Tyr Phe His Gly
Tyr Gly Phe His
Tyr Gly His Phe
Tyr His Phe Gly
Tyr His Gly Phe
Isolariciresinol 9-O-b-D-glucoside
Icariside E5
Constituent of ripe fruits of Capsicum annuum variety acuminatum. Icariside E5 is found in many foods, some of which are green bell pepper, yellow bell pepper, red bell pepper, and herbs and spices.
(7'R,8'R)-4,7'-Epoxy-3',5-dimethoxy-4',9,9'-lignanetriol 9'-glucoside
Isolariciresinol 9'-O-b-D-glucoside
Isolariciresinol 4'-O-b-D-glucoside
5-[3-(Hydroxymethyl)-5-(3-hydroxypropyl)-7-methoxy-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenyl hexopyranoside
Vanoxerine dihydrochloride
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators
terbium(3+),1,2,3,4-tetramethylcyclopenta-1,3-diene
nigrasin G
An extended flavonoid that is 5a,10a-dihydro-11H-[1]benzofuro[3,2-b]chromen-11-one substituted by hydroxy groups at positions 1, 3, 8 and 10a and a 3-hydroxy-2,6,10-trimethyldodeca-1,6,10-trien-12-yl group at position 5a. It has been isolated from the twigs of Morus nigra.
1-[4-[[4-[(5-Cyclopentyl-1h-Pyrazol-3-Yl)amino]pyrimidin-2-Yl]amino]phenyl]-3-[3-(Trifluoromethyl)phenyl]urea
[[(2R,3R)-2,3-Dihydro-2-(4-hydroxy-3-methoxyphenyl)-5-(3-hydroxypropyl)-7-methoxybenzofuran-3-yl]methyl]beta-D-glucopyranoside
2-[4-[4-[(4-Hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
2-[[2-(4-Hydroxy-3-methoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-3-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
methyl (4S,5E,6S)-5-ethylidene-4-[2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl]-6-[(1R,2R,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxy-4H-pyran-3-carboxylate
Baeckea frutescens 6
D001697 - Biomedical and Dental Materials > D003764 - Dental Materials
3-[[2,3-Dihydro-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxybenzofuran]-5-yl]propyl beta-D-glucopyranoside
(2S)-2-[(4R,5R)-4-methyl-5-[[methyl(pyrimidin-5-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
C28H34N4O4S (522.2300644000001)
(3S)-2-tert-butylsulfinyl-3-(2-hydroxyethyl)-4-[3-(3-methoxyphenyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxylic acid ethyl ester
(2S)-2-[(4R,5S)-4-methyl-5-[[methyl(pyrimidin-5-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
C28H34N4O4S (522.2300644000001)
N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylbenzenesulfonamide
N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylbenzenesulfonamide
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
C28H34N4O4S (522.2300644000001)
(2R)-2-[(4S,5S)-4-methyl-5-[[methyl(pyrimidin-5-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
C28H34N4O4S (522.2300644000001)
(2R)-2-[(4R,5R)-4-methyl-5-[[methyl(pyrimidin-5-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
C28H34N4O4S (522.2300644000001)
(2S)-2-[(4S,5R)-4-methyl-5-[[methyl(pyrimidin-5-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
C28H34N4O4S (522.2300644000001)
N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylbenzenesulfonamide
N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylbenzenesulfonamide
N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylbenzenesulfonamide
N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylbenzenesulfonamide
(3R)-2-tert-butylsulfinyl-3-(2-hydroxyethyl)-4-[3-(3-methoxyphenyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxylic acid ethyl ester
5-[(E)-2-[(2S,3R,4S)-3-ethenyl-5-methoxycarbonyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-4-yl]ethenyl]-1-ethylpyridin-1-ium-3-carboxylic acid
(2S,3R,4S)-4-[(E)-2-[1-(3-carboxypropyl)pyridin-1-ium-3-yl]ethenyl]-3-ethenyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carboxylic acid
(+)-Isolariciresinol-3alpha-O-beta-D-glucopyranoside
Methyl 3-[3,4-dihydroxy-2-(3-methylbut-2-enyl)phenyl]-2-[[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]methyl]-4-methoxy-5-oxofuran-2-carboxylate
(2-Benzamido-3-phenylpropyl) 2-benzamido-3-(4-hydroxyphenyl)propanoate
(7R,8R)-4,7-Epoxy-3,5-dimethoxy-4,9,9-lignanetriol 9-glucoside
BF 6
An organic heterotetracyclic compound that is 8,12-dihydro-2H,9H-pyrano[2,3-a]xanthene-4,9,11(3H,10H)-trione substituted by methyl groups at positions 6, 8, 8, 10 and 10 and phenyl groups at positions 2 and 12 respectively (the S-enantiomer). It is isolated from the leaves of Baeckea frutescens and exhibits cytotoxicity against leukemia cells.
2-hydroxy-3-(1-hydroxyheptyl)-10-[(4e)-1,2,6-trihydroxyhex-4-en-1-yl]-6,14-dioxatricyclo[10.3.0.0⁴,⁸]pentadeca-1(12),4(8)-diene-5,7,13,15-tetrone
(1s,2r,6s,7s,9r,12r,13r)-12-(acetyloxy)-13-[(acetyloxy)methyl]-9-methyl-5-methylidene-4-oxo-3,14-dioxatricyclo[7.4.1.0²,⁶]tetradecan-7-yl (2e)-2-[(acetyloxy)methyl]but-2-enoate
2-{[7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-6-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy}oxane-3,4,5-triol
(4as,10ar)-5-hydroxy-7-[(2s)-2-hydroxypropyl]-2,4a-dimethyl-9-oxo-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4,10,10a-tetrahydrophenanthrene-1-carboxylic acid
5-[(1r,2s)-2-{4-[(2r,3s,4s,5s)-5-(2h-1,3-benzodioxol-5-yl)-3,4-dimethyloxolan-2-yl]-2-methoxyphenoxy}-1-hydroxypropyl]-2-methoxyphenol
(8s,9s,10s)-14-hydroxy-3,4,5,15,16-pentamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2(7),3,5,13,15-hexaen-8-yl benzoate
methyl 10,15,16-trihydroxy-9,13-dimethyl-3-[(3-methylbutanoyl)oxy]-4,11-dioxo-5,18-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadec-9-ene-17-carboxylate
(2r,3r,4s,5s,6r)-2-{[(2s,3r,4r)-2-(4-hydroxy-3-methoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-3-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-{[8-(4-hydroxy-3-methoxyphenyl)-6,7-bis(hydroxymethyl)-3-methoxy-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
5-[(1r,2r)-2-{4-[(2s,3r,4r,5s)-5-(2h-1,3-benzodioxol-5-yl)-3,4-dimethyloxolan-2-yl]-2-methoxyphenoxy}-1-hydroxypropyl]-2-methoxyphenol
(2r)-4-[(1r,2r)-2-[(e)-2,3-dimethyloxirane-2-carbonyloxy]-1-(7-methoxy-2h-1,3-benzodioxol-5-yl)propoxy]-3-hydroxy-3-methyl-4-oxobutan-2-yl (2e)-2-methylbut-2-enoate
methyl (2r,4ar,8r,10ar,10br)-2-(furan-3-yl)-10b-methyl-4-oxo-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,4ah,5h,6h,8h,9h,10h,10ah-naphtho[2,1-c]pyran-7-carboxylate
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2r,3e)-4-[(1r)-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl]but-3-en-2-yl]oxy}oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
2-{2-[1-hydroxy-3-(3-hydroxy-5-methoxyphenyl)propan-2-yl]-4-(3-hydroxyprop-1-en-1-yl)-6-methoxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
9,19-dimethoxy-18-methyl-5,13-diphenyl-4,12,14-trioxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁵,²⁰]henicosa-2(11),3(8),9,15,17,19-hexaen-17-ol
(2s,3r,4s,5s,6r)-2-{2-[1-hydroxy-3-(3-hydroxy-5-methoxyphenyl)propan-2-yl]-4-[(1e)-3-hydroxyprop-1-en-1-yl]-6-methoxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-hydroxy-3-(1-hydroxyheptyl)-10-(1,2,6-trihydroxyhex-4-en-1-yl)-6,14-dioxatricyclo[10.3.0.0⁴,⁸]pentadeca-1(12),4(8)-diene-5,7,13,15-tetrone
(2e)-6-{3-[5-(2,5-dihydroxyphenyl)-2-oxo-5h-furan-3-yl]propyl}-7-hydroxy-2-methylhept-2-en-1-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate
(9r,10s)-10-hydroxy-4,5,14,15,16-pentamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2(7),3,5,13,15-hexaen-3-yl benzoate
(8r,9s,10r)-8-hydroxy-4,5,14,15,16-pentamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2(7),3,5,13,15-hexaen-3-yl benzoate
(7r,21r)-4,17-dihydroxy-7,21-bis(2-hydroxypropan-2-yl)-10-(3-methylbut-2-en-1-yl)-8,12,20-trioxapentacyclo[11.9.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]docosa-1(13),3,5(9),10,14,16,18-heptaen-2-one
(2s,12s)-5-hydroxy-6,8,8,10,10-pentamethyl-2,12-diphenyl-3,12-dihydro-2h-1,7-dioxatetraphene-4,9,11-trione
2-[4,5-dimethoxy-2-(3-phenyl-trans-allyloxy)benzyl]-5-hydroxy-6-methoxy-3-phenylbenzo-furan
{"Ingredient_id": "HBIN004226","Ingredient_name": "2-[4,5-dimethoxy-2-(3-phenyl-trans-allyloxy)benzyl]-5-hydroxy-6-methoxy-3-phenylbenzo-furan","Alias": "NA","Ingredient_formula": "C33H30O6","Ingredient_Smile": "COC1=C(C=C(C(=C1)CC2=C(C3=CC(=C(C=C3O2)OC)O)C4=CC=CC=C4)OCC=CC5=CC=CC=C5)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6275","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-[4,5-dimethoxy-5-(3-phenyl-trans-allyl)cyclo-hexa-3,6-dien-2-on-1-ylmethyl]-5-hydroxy-6-methoxy-3-phenylbenzofuran
{"Ingredient_id": "HBIN004227","Ingredient_name": "2-[4,5-dimethoxy-5-(3-phenyl-trans-allyl)cyclo-hexa-3,6-dien-2-on-1-ylmethyl]-5-hydroxy-6-methoxy-3-phenylbenzofuran","Alias": "NA","Ingredient_formula": "C33H30O6","Ingredient_Smile": "COC1=CC(=O)C(=CC1(CC=CC2=CC=CC=C2)OC)CC3=C(C4=CC(=C(C=C4O3)OC)O)C5=CC=CC=C5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6274","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(?)-5'-methoxyisolariciresinol-2α-o-β-d-xylopy-ranoside
{"Ingredient_id": "HBIN011761","Ingredient_name": "(?)-5'-methoxyisolariciresinol-2\u03b1-o-\u03b2-d-xylopy-ranoside","Alias": "NA","Ingredient_formula": "C26H34O11","Ingredient_Smile": "COC1=CC(=CC(=C1O)OC)C2C(C(CC3=CC(=C(C=C23)O)OC)CO)COC4C(C(C(CO4)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13970","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(-)-5'-methoxyisolariciresinol-2a-o-??-d-xylopyranoside
{"Ingredient_id": "HBIN011762","Ingredient_name": "(-)-5'-methoxyisolariciresinol-2a-o-??-d-xylopyranoside","Alias": "NA","Ingredient_formula": "C26H34O11","Ingredient_Smile": "COC1=CC(=CC(=C1O)OC)C2C(C(CC3=CC(=C(C=C23)O)OC)CO)COC4C(C(C(CO4)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31554","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
alboside ii
{"Ingredient_id": "HBIN015088","Ingredient_name": "alboside ii","Alias": "NA","Ingredient_formula": "C26H34O11","Ingredient_Smile": "CC1C(CC2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)OC(=O)C=CC4=CC(=C(C=C4)OC)OC)O","Ingredient_weight": "522.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "868","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "100982916","DrugBank_id": "NA"}
Benzoylgomisin H
{"Ingredient_id": "HBIN017813","Ingredient_name": "Benzoylgomisin H","Alias": "benzoylgomisin h","Ingredient_formula": "C30H34O8","Ingredient_Smile": "CC1CC2=CC(=C(C(=C2C3=C(C(=C(C=C3CC1(C)O)OC)OC)OC)OC(=O)C4=CC=CC=C4)OC)OC","Ingredient_weight": "522.6 g/mol","OB_score": "7.510450706","CAS_id": "NA","SymMap_id": "SMIT10159","TCMID_id": "2240","TCMSP_id": "MOL008960","TCM_ID_id": "NA","PubChem_id": "14992069","DrugBank_id": "NA"}